FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
FinEx Metals Granted Exploration License For Kero Project in Finland, Adding District-Scale Gold Upside Near Kittila and Ikkari Deposits
Osisko Metals Launches Deep Porphyry Exploration Project and Confirms 852 Metres Averaging 0.95% CuEq at Historic Porphyry Mountain Deposit
Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent to America’s only Antimony Smelter
